about
Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VIEnzyme replacement therapy with galsulfase for mucopolysaccharidosis type VIAttenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literatureAnaesthesia and airway management in mucopolysaccharidosis.Anti-TNF-alpha therapy enhances the effects of enzyme replacement therapy in rats with mucopolysaccharidosis type VIArylsulfatase B modulates neurite outgrowth via astrocyte chondroitin-4-sulfate: dysregulation by ethanolSensory-motor behavioral characterization of an animal model of Maroteaux-Lamy syndrome (or Mucopolysaccharidosis VI).Molecular Analysis of Turkish Maroteaux-Lamy Patients and Identification of One Novel Mutation in the Arylsulfatase B (ARSB) GeneBiomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and managementPaleopathological Study of Dwarfism-Related Skeletal Dysplasia in a Late Joseon Dynasty (South Korean) PopulationDiagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfallsA review of gene therapy in canine and feline models of lysosomal storage disorders.Mucopolysaccharidosis VI in cats - clarification regarding genetic testingDiagnostic and treatment strategies in mucopolysaccharidosis VI.Novel mutations of the arylsulphatase B (ARSB) gene in Indian patients with mucopolysaccharidosis type VI.Combined Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation in Mucopolysacharidosis Type VI.Molecular findings of Colombian patients with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome).Mutations in ARSB in MPS VI patients in India.Long-term cognitive follow-up in children treated for Maroteaux-Lamy syndrome.Pharmacological read-through of nonsense ARSB mutations as a potential therapeutic approach for mucopolysaccharidosis VIIdentification of a novel arylsulfatase B gene mutation in three unrelated Iranian mucopolysaccharidosis type-VI patients with different phenotype severity.Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase.Structural, compositional, and biomechanical alterations of the lumbar spine in rats with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).Spondyloepiphyseal dysplasias and bilateral legg-calvé-perthes disease: diagnostic considerations for mucopolysaccharidosesHaploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome.Energy expenditure during gait in patients with mucopolysaccharidosis.Rapid Desensitization for Immediate Hypersensitivity to Galsulfase Therapy in Patients with MPS VI.Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: A case report.Benign joint hypermobility syndrome among children with inguinal herniaMucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose.Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases.Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing.Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy.Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI.Overview of the mucopolysaccharidoses.Diagnosis of the mucopolysaccharidoses.Therapy for the mucopolysaccharidoses.Mucopolysaccharidoses.Current and potential therapeutic strategies for mucopolysaccharidoses.
P2860
Q24186047-611E9A33-7F8A-4D24-9864-4C3E02F57E1BQ24198820-54105233-0A48-4AFA-A5C4-84155DE31B2CQ26830003-1E563BF5-3E2A-4AE1-A4B1-4D48A7469F5AQ26996429-804C516E-8FE0-4940-A7CF-8AF105541255Q28476636-A221B581-5096-48BC-99E2-4DC7471C3082Q28571230-391004BC-44CF-4DAA-B65A-2EEBD7C4874DQ30563980-17F6F873-DAAE-40BA-BBC6-A4643D958DD0Q34422329-A521E065-CDCD-4185-8063-FDA4BF4133F0Q35570893-D6F2EDDD-F765-4414-9C3B-5FE670ECF748Q35587435-03445C0D-E00F-4740-8556-865EC741F18FQ35815778-12116396-DD65-4654-948C-054571D0A60BQ35836716-3DA8694E-C9C8-4B08-82AE-3387B9876F06Q35894676-E0CB09DF-937A-4518-AAD4-217E452BF2C9Q36066425-91091610-7C6D-401C-BE54-35AD74BF6DDDQ36253221-3A8C3A0E-67D0-4609-B6C7-E3719361DD05Q36383660-EF42DF9E-B357-493E-AEEB-1864F1154A01Q36433293-3E222352-D523-4814-B755-9A6E66281328Q36521405-CC77DCB1-7EE5-4D03-8824-0A273A58FB64Q36571593-189EF529-EE66-4C91-A904-07F2808BE8C3Q36582221-0873BA7F-F64F-4509-A67F-5CB0879DD43CQ36662823-8042E473-1F61-40FC-9427-7C3822A1A703Q36777136-A1189564-9366-48E6-87F6-477AAE166A16Q36797802-A51AA1BC-ED7D-41B7-B9F2-5AF70BB7C8C3Q36821152-DECEAA80-4EB4-4F8B-B789-456E5B962771Q37127617-C443457D-2D83-4E09-99C2-B0F0B5330A88Q37154973-DF5CF0D8-1533-4F39-98B1-733BABAD6FAAQ37389527-A21823EB-A12A-4639-B197-92D439C55389Q37415853-6C2DD0A6-9F11-4A79-94DD-BB88645A6B44Q37434238-0C88B467-3077-406F-A7FE-65CF0CDC789CQ37498249-B7697D5E-11CD-4C97-9B24-44A5A26E6137Q37515209-81D8E80E-A6DA-45CA-97AA-94FD23A44EA5Q37595934-AC818C68-58D1-4DD3-BCAE-920D80252638Q37615837-3B7B780E-6634-4AF3-B802-F4D35D6A4CC9Q37670302-5FCD8CCD-2D4B-4FAA-89DB-6956C501DCDCQ37686034-CDF0AE52-4646-49A5-99CA-E09C6923E3BAQ37972589-B3C958CA-60E8-4626-9896-2C4A03437BFEQ37972590-398F985D-A382-4005-BD30-F4287354AE92Q37972592-838E5455-CBAB-488A-87C1-D3DCB8369184Q38165092-39425E0A-4339-4D08-8372-A05316CD628CQ38194635-D2FFE55A-EFAA-4751-ABF9-B7840170AB8F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mucopolysaccharidosis VI.
@ast
Mucopolysaccharidosis VI.
@en
type
label
Mucopolysaccharidosis VI.
@ast
Mucopolysaccharidosis VI.
@en
prefLabel
Mucopolysaccharidosis VI.
@ast
Mucopolysaccharidosis VI.
@en
P2093
P2860
P356
P1476
Mucopolysaccharidosis VI.
@en
P2093
Helen Nicely
Paul Harmatz
Sean Turbeville
P2860
P2888
P356
10.1186/1750-1172-5-5
P5008
P577
2010-04-12T00:00:00Z
P5875
P6179
1042691390